title: [Not Available].
authors.affiliation: Medicines Development and Training (MDT) services et service de dermatologie, hôpital Tenon, 75020 Paris, France.
authors.forename: Mira
authors.initials: M
authors.lastname: Pavlovic
authors.affiliation: Celgene, 75002 Paris, France.
authors.forename: Jérôme
authors.initials: J
authors.lastname: Garnier
authors.affiliation: Inserm UMRS 1123, hôpital Henri-Mondor, université Paris Est Créteil, AP-HP, 75004 Paris, France; URCEco Île-de-France, hôpital de l'Hôtel-Dieu, 1, place du Parvis-de-Notre-Dame, 75004 Paris, France. Electronic address: isabelle.durand-zaleski-ext@aphp.fr.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Durand-Zaleski
mesh_terms: D018572:Disease-Free Survival; D005060:Europe; D005602:France; D006801:Humans; D008495:Medical Oncology / Q000191:economics / Q000706:statistics & numerical data*; D009369:Neoplasms / Q000191:economics / Q000523:psychology* / Q000628:therapy*; D016019:Survival Analysis
keywords: Haute Autorité de santé; IQWIG; NICE; Oncologie; Ratio différentiel coût-résultat; Survie; Survie sans progression; Évaluation médicoéconomique